Reinhard Stauder
19PUBLICATIONS
64CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (19)
Sort by Publication Date:
|Mar 11, 2023
Health-Related Quality of Life as Assessed by the EQ-5D-5L Predicts Outcomes of Patients Treated with Azacitidine-A Prospective Cohort Study by the AGMT.Lisa Pleyer, Sonja Heibl, Christoph Tinchon
|Feb 01, 2023
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes.Amer M Zeidan, Uwe Platzbecker, Jan Philipp Bewersdorf
|Jan 06, 2023
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study.Igor Stojkov, Annette Conrads-Frank, Ursula Rochau
|Nov 06, 2022
Cause of death and excess mortality in patients with lower-risk myelodysplastic syndromes (MDS): A report from the European MDS registry.Krzysztof Mądry, Karol Lis, Pierre Fenaux
|May 28, 2022
Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents-A Prospective Cohort Study of the AGMT Study-Group.Michael Leisch, Michael Pfeilstöcker, Reinhard Stauder
Pageof 4
Frequent Collaborators
4 joint publications
Luca Malcovati
4 joint publications
Argiris Symeonidis
4 joint publications
Karin A Koinig
4 joint publications
Corine van Marrewijk
4 joint publications
Alexandra Smith
3 joint publications
Guillermo Sanz
3 joint publications
Heinz Sill
3 joint publications
Peter Valent
3 joint publications
Pierre Fenaux
3 joint publications
Sonja Heibl